We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FCSC
151
DELISTED
Fibrocell Science Inc.
FCSC
| $211K | 0.13% |
2,667
-666
| -20% | -$44.8K |
2013 Q4
6 quarters
|
|
|
CSBK
152
DELISTED
Clifton Bancorp Inc.
CSBK
| $210K | 0.13% |
15,000
| – | – |
2014 Q2
4 quarters
|
|
153
Seres Therapeutics
MCRB
$27.2M
| $208K | 0.13% |
+250
| New | +$218K |
2015 Q2
0 quarters
|
|
|
XLRN
154
DELISTED
Acceleron Pharma
XLRN
| $206K | 0.13% |
6,500
| – | – |
2014 Q4
2 quarters
|
|
155
EQT Corp
EQT
$33.3B
| $203K | 0.13% |
+4,593
| New | +$215K |
2015 Q2
0 quarters
|
|
156
Popular Inc
BPOP
$10B
| $202K | 0.13% |
7,000
-8,000
| -53% | -$269K |
2014 Q1
5 quarters
|
|
157
CALL
Marvell Technology
MRVL
$239B
| $198K | 0.12% |
+15,000
| New | +$215K |
2015 Q2
0 quarters
|
|
158
DELISTED
Cogentix Medical, Inc.
CGNT
| $198K | 0.12% |
+122,176
| New | +$200K |
2015 Q2
0 quarters
|
|
159
RAVE Restaurant Group
RAVE
$31.5M
| $196K | 0.12% |
15,000
-5,000
| -25% | -$66.4K |
2014 Q4
2 quarters
|
|
160
DELISTED
Primo Water Corporation
PRMW
| $196K | 0.12% |
+20,000
| New | +$191K |
2015 Q2
0 quarters
|
|
|
ENT
161
DELISTED
Global Eagle Entertainment Inc.
ENT
| $195K | 0.12% |
600
-400
| -40% | -$134K |
2014 Q3
3 quarters
|
|
162
Tilly's
TLYS
$138M
| $193K | 0.12% |
20,000
+10,000
| +100% | +$127K |
2015 Q1
1 quarter
|
|
163
CALL
Micron Technology
MU
$1.12T
| $188K | 0.12% |
10,000
-20,000
| -67% | -$533K |
2015 Q1
1 quarter
|
|
164
Vince Holding Corp
VNCE
$149M
| $180K | 0.11% |
1,500
+250
| +20% | +$41.8K |
2014 Q2
4 quarters
|
|
165
Pixelworks
PXLW
$34.9M
| $176K | 0.11% |
+2,500
| New | +$157K |
2015 Q2
0 quarters
|
|
166
Lipocine
LPCN
$14.3M
| $172K | 0.11% |
+1,176
| New | +$146K |
2015 Q2
0 quarters
|
|
|
NVCN
167
DELISTED
Neovasc Inc.
NVCN
| $171K | 0.11% |
1
| – | – |
2014 Q2
4 quarters
|
|
168
HomeTrust Bancshares
HTB
$761M
| $168K | 0.1% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
|
ZGNX
169
DELISTED
Zogenix, Inc.
ZGNX
| $168K | 0.1% |
12,500
| – | – |
2015 Q1
1 quarter
|
|
|
ARIA
170
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $165K | 0.1% |
20,000
+10,000
| +100% | +$88.4K |
2015 Q1
1 quarter
|
|
|
COWN
171
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $160K | 0.1% |
51,250
+6,250
| +14% | +$147K |
2013 Q2
8 quarters
|
|
172
ICICI Bank
IBN
$101B
| $156K | 0.1% |
16,500
| – | – |
2014 Q2
4 quarters
|
|
173
Rithm Capital
RITM
$4.77B
| $152K | 0.09% |
+10,000
| New | +$166K |
2015 Q2
0 quarters
|
|
174
DELISTED
Northfield Bancorp
NFBK
| $151K | 0.09% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
|
AVHI
175
DELISTED
A V Homes, Inc.
AVHI
| $144K | 0.09% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.